CardioComm Solutions, Inc. develops and sells advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, GlobalCardio, and HeartCheck SMART monitoring. It also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.
Frequently asked questions
What sector does CardioComm Solutions Inc (EKGGF) operate in?
CardioComm Solutions Inc belongs to the Healthcare sector and operates in the Health Information Services industry.
What is CardioComm Solutions Inc (EKGGF) current stock price?
As of the latest data, CardioComm Solutions Inc stock price is $0.01, with a previous close of $0.01.
What is CardioComm Solutions Inc (EKGGF) current market capitalization?
CardioComm Solutions Inc market cap is approximately 1.34 million.
What is CardioComm Solutions Inc (EKGGF) EBITDA?
CardioComm Solutions Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -98.95 thousand.
Does CardioComm Solutions Inc (EKGGF) pay dividends?
No. CardioComm Solutions Inc does not pay a dividend.
What is CardioComm Solutions Inc (EKGGF) beta (volatility) score?
CardioComm Solutions Inc has a beta of -1.937, indicating lower volatility than the overall market.